Researchers might have found the Holy Grail in the war against cancer, a miracle drug that has killed every kind of cancer tumor it has come in contact with.
The drug works by blocking a protein called CD47 that is essentially a “do not eat” signal to the body’s immune system, according to Science Magazine.
This protein is produced in healthy blood cells but researchers at Stanford University found that cancer cells produced an inordinate amount of the protein thus tricking the immune system into not destroying the harmful cells.
With this observation in mind, the researchers built an antibody that blocked cancer’s CD47 so that the body’s immune system attacked the dangerous cells.
So far, researchers have used the antibody in mice with human breast, ovary, colon, bladder, brain, liver and prostate tumors transplanted into them. In each of the cases the antibody forced the mice’s immune system to kill the cancer cells.
link to it
http://nypost.com/2013/03/27/one-drug-t ... cer-tumor/
Some news you all mite like [CD47]
Moderators: Site Moderators, FAHC Science Team
-
- Posts: 45
- Joined: Sat Oct 27, 2012 6:17 pm
- Hardware configuration: AMD Opteron 2 x 6274 (32 Cores)
AMD FX-8350 (8 Cores)
Intel i7-4790K (8 Cores)
Intel i7-4790K (8 Cores)
Intel i7-4771K (8 Cores)
Intel i7-3770K (8 Cores)
Intel i7-3770K (8 Cores)
Intel i7-3770K (8 Cores)
Intel i7-3770S (8 Cores)
Intel i7-3930K (12 Cores)
Nvidia GPUs:
GTX 780ti
GTX 780ti
GTX 780ti
GTX 780ti
GTX 780
GTX 690
GTX 690
AMD GPUs:
HD 7970 GBE
HD 7970 GBE
HD 7990
HD 7990
HD 7990
R9 295X2
R9 295X2
R9 295X2 - Location: Dallas, TX
Re: Some news you all mite like
This could be an amazing development, but until it's used in actual humans and demonstrates results, we just can't know for certain it will perform as it has in the laboratory with mice. That being said, I have my fingers crossed
-
- Posts: 1576
- Joined: Tue May 28, 2013 12:14 pm
- Location: Tokyo
Re: Some news you all mite like
Here some recent update from Stanford:
http://stemcell.stanford.edu/CD47/
http://stemcell.stanford.edu/CD47/
All of this takes time.
For the last year, many people have been working to make clinical trials possible. We are now hopeful that the first human clinical trials of anti-CD47 antibody will take place at Stanford in mid-2014, if all goes well. Clinical trials may also be done in the United Kingdom.
Please contribute your logs to http://ppd.fahmm.net